Invention Grant
- Patent Title: Anti-Sema3A antibodies and their uses for treating eye or ocular diseases
-
Application No.: US16869618Application Date: 2020-05-08
-
Publication No.: US11267880B2Publication Date: 2022-03-08
- Inventor: Leo Thomas , Rachel Rebecca Barrett , Kristin Laura Bovat , Rajkumar Ganesan , Priyanka Gupta , Fei Han , Dongmei Liu , Juergen Prestle , Sanjaya Singh , Sathyadevi Venkataramani , Helen Haixia Wu , Nina Zippel
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent David L. Kershner
- Priority: EP19173454 20190509
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K38/17 ; C07K14/47 ; A61P25/28 ; A61K9/00
Abstract:
The present invention relates to antibodies and fragments thereof that target semaphorin 3A (Sema3A). More specifically, anti-Sema3A antibodies and methods of use for the treatment of various diseases or disorders are disclosed.
Information query
